P
ProHub
English 简体中文 繁體中文
Medium Growth Strategy Merger & Acquisition Organic Growth vs. Acquisition Multi-site Operations

Smiles4Life

#Healthcare
ProHub Comment

This case requires candidates to evaluate three distinct growth levers (digital marketing, organic store expansion, and acquisition) and synthesize their cumulative EBITDA impact against a $9M target (75% increase from $3.6M baseline). The case emphasizes the importance of sequencing initiatives based on implementation timelines and risk profiles, rather than pursuing all opportunities simultaneously.

Estimated Time 26 minutes
Difficulty Medium
Source Darden
10 / 100
Smiles4Life is a regional dental company with 40 locations throughout Texas. The company is a dominate player in both Dallas and Houston, known to have especially strong ties to the Latin community. Last year, Smiles4Life did $60M in revenue with a 20% EBITDA margin after including corporate expenses. At this point, the owner/founder was ready to retire and decided to sell the company to Red Rock Capital, a PE fund based out of LA. Red Rock is excited about the new investment and is now focused on value creation. Red Rock engaged us to help diligence Smiles4Life and, being so pleased with their work, decided to engage us again to develop a growth strategy for its newest portfolio company. How would you advise?

Clarifying Information

  1. Growth target: Red Rock wants to increase EBITDA by 75% within three years of the investment.
  2. Business model: Smiles4Life generates revenue much like any typical dental office. Doctors treat patients. Patients then pay either in cash or through a benefit provider (commercial PPO insurance, Medicaid, HMO, etc…).
  3. Red Rock Capital: The PE fund focuses on investments across manufacturing, healthcare, and restaurants. It has successfully scaled many multi-site businesses before, especially in the restaurant industry.
Mock Interview
Interviewer

Smiles4Life is a regional dental company with 40 locations throughout Texas. The company is a dominate player in both Dallas and Houston, known to have especially strong ties to the Latin community. Last year, Smiles4Life did $60M in revenue with a 20% EBITDA margin after including corporate expenses. At this point, the owner/founder was ready to retire and decided to sell the company to Red Rock Capital, a PE fund based out of LA. Red Rock is excited about the new investment and is now focused on value creation. Red Rock engaged us to help diligence Smiles4Life and, being so pleased with their work, decided to engage us again to develop a growth strategy for its newest portfolio company. How would you advise?

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

A PE-backed dental company seeks to grow EBITDA 75% in three years. Candidates must analyze and compare three strategies: digital marketing ($2.7M EBITDA opportunity, 30% of goal), organic de novo expansion ($4.8M EBITDA opportunity, 53% of goal), and acquiring The Smile Center ($1.2M EBITDA opportunity, 13% of goal). The recommended approach combines all three with prioritized sequencing.

Key Insights:

  1. Digital marketing has the longest ramp-up period and should begin immediately despite generating only 30% of the EBITDA goal
  2. Organic de novo expansion leverages existing capabilities and represents the largest EBITDA opportunity at 53% of goal
  3. Together, digital marketing and de novo expansion create 83% of the EBITDA goal, suggesting acquisition may be tertiary
  4. The candidate must synthesize cumulative EBITDA contributions across initiatives to make a balanced, prioritized recommendation
  5. Risk factors differ by initiative: marketing requires customer segmentation; de novos face market saturation risk; acquisition carries integration risk